Literature DB >> 18386128

Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose.

O Caleo1, S Maurea, M Klain, B Salvatore, G Storto, M Mancini, L Pace, M Salvatore.   

Abstract

PURPOSE: The aim of this study was to compare the results of ultrasound (US), whole-body scintigraphy with iodine-131 (I-131 WBS) and positron emission tomography with fluorine-18 deoxyglucose (FDG-PET) in the follow-up of patients after thyroidectomy for differentiated thyroid carcinoma (DTC).
MATERIALS AND METHODS: Thirteen patients (3 men, 10 women) were evaluated by neck US, I-131 WBS and FDG-PET. In each patient six anatomical regions (right and left thyroid bed, right and left cervical region, right and left supraclavicular region) were investigated, for a total of 78 regions. Distant metastases were investigated by I-131 WBS and FDG-PET and considered separately in the analysis. Imaging findings were compared with the reference standards, such as fine-needle aspiration cytology (2), biopsy (4) or clinical-radiological studies (7).
RESULTS: US, FDG-PET and I-131 WBS showed concordant negative results in most (70, 90%) of the anatomical sites considered. In one patient with left cervical lymph node metastasis, the imaging techniques showed concordant positive results (1%). In the remaining 7 regions (9%), the imaging results were discordant; in particular, tumour lesions, nodal metastases (4) and thyroid bed recurrences (3) were detected by US only (3), by US and I-131 WBS (1) and by FDG-PET only (3). With regard to distant metastases, FDG-PET and I-131 WBS yielded concordant negative results in the majority (77%) of patients (9); in one patient only were the two imaging techniques concordant in their positive result. In the last three patients, the results were discordant; in particular, distant metastases were detected by I-131 WBS only in two patients and by FDG-PET only in one patient.
CONCLUSIONS: Our work indicates a fundamental role for US in evaluation of the neck after surgery for DTC. WBS is useful to determine differentiation of tumour lesions, to identify thyroid remnants and to look for distant metastases. FDG-PET has an important role in cases of dedifferentiated thyroid carcinoma in which WBS and thyroglobulin measurements are unable to detect tumour lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18386128     DOI: 10.1007/s11547-008-0243-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  14 in total

Review 1.  Thyroid ultrasound.

Authors:  L Hegedüs
Journal:  Endocrinol Metab Clin North Am       Date:  2001-06       Impact factor: 4.741

2.  Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt
Journal:  Thyroid       Date:  2003-01       Impact factor: 6.568

3.  Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.

Authors:  M Klain; S Maurea; A Cuocolo; A Colao; L Marzano; G Lombardi; M Salvatore
Journal:  Eur J Nucl Med       Date:  1996-12

Review 4.  An overview of the management of papillary and follicular thyroid carcinoma.

Authors:  E L Mazzaferri
Journal:  Thyroid       Date:  1999-05       Impact factor: 6.568

5.  Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management.

Authors:  Holger Palmedo; Jan Bucerius; Alexius Joe; Holger Strunk; Niclas Hortling; Susanne Meyka; Roland Roedel; Martin Wolff; Eva Wardelmann; Hans-Juergen Biersack; Ursula Jaeger
Journal:  J Nucl Med       Date:  2006-04       Impact factor: 10.057

6.  Usefulness of ultrasonography in the management of nodular thyroid disease.

Authors:  E Marqusee; C B Benson; M C Frates; P M Doubilet; P R Larsen; E S Cibas; S J Mandel
Journal:  Ann Intern Med       Date:  2000-11-07       Impact factor: 25.391

7.  Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer.

Authors:  Massimo Torlontano; Umberto Crocetti; Leonardo D'Aloiso; Nazario Bonfitto; Anna Di Giorgio; Sergio Modoni; Guido Valle; Vincenzo Frusciante; Michele Bisceglia; Sebastiano Filetti; Martin Schlumberger; Vincenzo Trischitta
Journal:  Eur J Endocrinol       Date:  2003-01       Impact factor: 6.664

Review 8.  Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer.

Authors:  L Mansi; R Moncayo; V Cuccurullo; M E Dottorini; P F Rambaldi
Journal:  Q J Nucl Med Mol Imaging       Date:  2004-06       Impact factor: 2.346

Review 9.  Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective.

Authors:  Martin Schlumberger; Gertrud Berg; Ohad Cohen; Leonidas Duntas; François Jamar; Barbara Jarzab; Eduard Limbert; Peter Lind; Furio Pacini; Christoph Reiners; Franco Sánchez Franco; Anthony Toft; Wilmar M Wiersinga
Journal:  Eur J Endocrinol       Date:  2004-02       Impact factor: 6.664

10.  Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.

Authors:  Andrea Frasoldati; Marialaura Pesenti; Marco Gallo; Angelo Caroggio; Diana Salvo; Roberto Valcavi
Journal:  Cancer       Date:  2003-01-01       Impact factor: 6.860

View more
  1 in total

1.  Therapeutic impact of (18)F-FDG PET/CT in recurrent differentiated thyroid carcinoma.

Authors:  Fabio Pomerri; Anna Rita Cervino; Faise Al Bunni; Laura Evangelista; Pier Carlo Muzzio
Journal:  Radiol Med       Date:  2013-11-26       Impact factor: 3.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.